SURFACE EXPRESSION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR IN EBV-TRANSFORMED LYMPHOCYTES - CHARACTERIZATION AND USE FOR STUDYING FAMILIAL HYPERCHOLESTEROLEMIA
Pc. Chan et al., SURFACE EXPRESSION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR IN EBV-TRANSFORMED LYMPHOCYTES - CHARACTERIZATION AND USE FOR STUDYING FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 131(2), 1997, pp. 149-160
The objectives of the present study were to characterize the surface e
xpression of low density lipoprotein receptor (LDL-R) in Epstein-Barr
virus transformed lymphocytes (EBV-L) and to determine the applicabili
ty of the cellular system for the study of familial hypercholesterolem
ia. The EBV-L subsets and LDL-R expression were determined by immuno-c
ytofluorimetry. The LDL-R expression in EBV-L which consisted of mostl
y B cells was no different among antigenic subsets. EBV-L cultured in
lipoprotein deficient serum demonstrated a 9.3-fold higher LDL-R expre
ssion than primary lymphocytes. Lovastatin caused an additional 1.9-an
d 1.4-fold increase in EBV-L and primary lymphocytes respectively. Thi
s difference in lovastatin response is statistically significant (pair
ed t-test, P < 0.001). 54% Of the high LDL-R expression in EBV-L was r
elated to the changes in proliferation measured as stimulation index (
SI). LDL and lovastatin modulated the LDL-R expression without affecti
ng SI. FH subjects demonstrated 2% (homozygote, n = 1) and 44.6 +/- 12
.3% (heterozygotes, n = 35) in LDL-R expression of controls (n = 30).
This maintenance of the FH phenotype and the intrinsically high LDL-R
expression in EBV-L make the cellular system suitable for the study of
FH as well as the regulation of LDL-R. (C) 1997 Elsevier Science Irel
and Ltd.